Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

Anti-Staphylococcus aureus Alpha-toxin/hly Antibody (SAA0345)

Catalog #:   RXX00102 Specific References (50) DATASHEET
Host species: Human
Isotype: IgG1
Applications: ELISA
Accession: P09616
Overview

Catalog No.

RXX00102

Species reactivity

Staphylococcus aureus

Host species

Human

Isotype

IgG1

Clonality

Monoclonal

Target

Alpha-hemolysin, hly, Alpha-HL, Alpha-toxin, hla

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P09616

Applications

ELISA

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

SAA0345

Data Image
References

Imaging oligomers of alpha-toxin (Hla) variants using high-speed AFM and neutralizing Hla hemolytic activity with their antisera., PMID:40147500

Highly sensitive detection of Staphylococcus aureus α-hemolysin protein (Hla or α-toxin) by apta-qPCR., PMID:39742925

Enhanced Staphylococcus aureus protection by uncoupling of the α-toxin-ADAM10 interaction during murine neonatal vaccination., PMID:39379345

α-Hemolysin-mediated endothelial injury contributes to the development of Staphylococcus aureus-induced dermonecrosis., PMID:38953668

In vivo mRNA expression of a multi-mechanistic mAb combination protects against Staphylococcus aureus infection., PMID:38822525

A High-Homology Region Provides the Possibility of Detecting β-Barrel Pore-Forming Toxins from Various Bacterial Species., PMID:38791367

In Vivo Detection of Staphylococcus aureus Infections Using Radiolabeled Antibodies Specific for Bacterial Toxins., PMID:38665417

Facile construction of sandwich ELISA based on double-nanobody for specific detection of α-hemolysin in food samples., PMID:38569370

Investigation of Staphylococcus aureus Biofilm-Associated Toxin as a Potential Squamous Cell Carcinoma Therapeutic., PMID:38399697

Toxin-neutralizing Abs are associated with improved T cell function following recovery from Staphylococcus aureus infection., PMID:38236641

A randomised, double-blind, placebo-controlled, first-in-human phase I study to characterise the safety, pharmacokinetics and immunogenicity of 9MW1411 in healthy Chinese subjects., PMID:38157918

Monoclonal antibodies neutralizing alpha-hemolysin, bicomponent leukocidins, and clumping factor A protected against Staphylococcus aureus-induced acute circulatory failure in a mechanically ventilated rabbit model of hyperdynamic septic shock., PMID:37781371

Mechanism of Action for an All-in-One Monoclonal Antibody Against Staphylococcus aureus Infection., PMID:37335928

Anti-Alpha-Toxin Antibody Responses and Clinical Outcomes of Staphylococcus aureus Bacteremia., PMID:37096312

New Molecular and Biological Markers in Cutaneous T Cell Lymphoma: Therapeutic Implications., PMID:37017872

Identification of two neutralizing human single-chain variable fragment antibodies targeting Staphylococcus aureus alpha-hemolysin., PMID:36311199

A novel gyrase inhibitor from toxin-antitoxin system expressed by Staphylococcus aureus., PMID:36148483

Staphylococcus aureus Alpha-Toxin in Deep Tracheal Aspirates-Preliminary Evidence for Its Presence in the Lungs of Sepsis Patients., PMID:35878188

Performance of the Cepheid Methicillin-Resistant Staphylococcus aureus/S. aureus Skin and Soft Tissue Infection PCR Assay on Respiratory Samples from Mechanically Ventilated Patients for S. aureus Screening during the Phase 2 Double-Blind SAATELLITE Study., PMID:35758652

A novel fully human recombinant antibody neutralizing α-hemolysin of Staphylococcus aureus., PMID:35751523

Neutralizing Staphylococcus aureus Virulence with AZD6389, a Three mAb Combination, Accelerates Closure of a Diabetic Polymicrobial Wound., PMID:35642538

Human OTULIN haploinsufficiency impairs cell-intrinsic immunity to staphylococcal α-toxin., PMID:35587511

Capture and identification of bacteria from fish muscle based on immunomagnetic beads and MALDI-TOF MS., PMID:35498980

Antibiotic Treatment of Staphylococcus aureus Infection Inhibits the Development of Protective Immunity., PMID:35266822

Efficacy of immunization with a recombinant S. aureus vaccine formulated with liposomes and ODN-CpG against natural S. aureus intramammary infections in heifers and cows., PMID:35219182

[Preparation and functional identification of human single chain recombinant antibody targeting α-hemolysin of Staphylococcus aureus]., PMID:34906299

Immunoinformatics analysis and evaluation of recombinant chimeric triple antigen toxoid (r-HAB) against Staphylococcus aureus toxaemia in mouse model., PMID:34609523

Antibiotic Combined with Epitope-Specific Monoclonal Antibody Cocktail Protects Mice Against Bacteremia and Acute Pneumonia from Methicillin-Resistant Staphylococcus aureus Infection., PMID:34511967

Bacterial Type I Toxins: Folding and Membrane Interactions., PMID:34357962

Identification of a Human Anti-Alpha-Toxin Monoclonal Antibody Against Staphylococcus aureus Infection., PMID:34335518

Development of Combination Vaccine Conferring Optimal Protection against Six Pore-Forming Toxins of Staphylococcus aureus., PMID:34227839

Impaired T-Lymphocyte Responses During Childhood Staphylococcus aureus Infection., PMID:34145461

Immunodominance of Epitopes and Protective Efficacy of HI Antigen Are Differentially Altered Using Different Adjuvants in a Mouse Model of Staphylococcus aureus Bacteremia., PMID:34122448

Multimechanistic Monoclonal Antibody Combination Targeting Key Staphylococcus aureus Virulence Determinants in a Rabbit Model of Prosthetic Joint Infection., PMID:33903108

Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial., PMID:33894131

Identification and application of a neutralizing epitope within alpha-hemolysin using human serum antibodies elicited by vaccination., PMID:33873093

IBT-V02: A Multicomponent Toxoid Vaccine Protects Against Primary and Secondary Skin Infections Caused by Staphylococcus aureus., PMID:33777005

Development of a mechanism of action reflective and robust potency assay for a therapeutic antibody against alpha toxin using rabbit erythrocytes., PMID:33075362

Antibody-Mediated Protection against Staphylococcus aureus Dermonecrosis: Synergy of Toxin Neutralization and Neutrophil Recruitment., PMID:32946878

Vaccination with VLPs Presenting a Linear Neutralizing Domain of S. aureus Hla Elicits Protective Immunity., PMID:32664481

Design of Staphylococcus aureus New Vaccine Candidates with B and T Cell Epitope Mapping, Reverse Vaccinology, and Immunoinformatics., PMID:32286190

Effects of isosorbide mononitrate loaded nanoparticles conjugated with anti-Staphylococcus aureus α-toxin on Staphylococcus aureus biofilms., PMID:32010298

Efficacy of Active Immunization With Attenuated α-Hemolysin and Panton-Valentine Leukocidin in a Rabbit Model of Staphylococcus aureus Necrotizing Pneumonia., PMID:31504652

Associations of pathogen-specific and host-specific characteristics with disease outcome in patients with Staphylococcus aureus bacteremic pneumonia., PMID:31360464

Survival during influenza-associated bacterial superinfection improves following viral- and bacterial-specific monoclonal antibody treatment., PMID:31341107

Sono-Immunotherapeutic Nanocapturer to Combat Multidrug-Resistant Bacterial Infections., PMID:31222947

Rational Design of Toxoid Vaccine Candidates for Staphylococcus aureus Leukocidin AB (LukAB)., PMID:31207937

Candida albicans Augments Staphylococcus aureus Virulence by Engaging the Staphylococcal agr Quorum Sensing System., PMID:31164467

Role and plasticity of Th1 and Th17 responses in immunity to Staphylococcus aureus., PMID:31149870

Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Study of the Penetration of a Monoclonal Antibody Combination (ASN100) Targeting Staphylococcus aureus Cytotoxins in the Lung Epithelial Lining Fluid of Healthy Volunteers., PMID:31138568

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1860

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Staphylococcus aureus Alpha-toxin/hly Antibody (SAA0345) [RXX00102]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only